Toxicology of fluoroacetate: A review, with possible directions for therapy research

Journal of Applied Toxicology

Volumn 26, Issue 2, 2006, Pages 148-161

  Goncharov, Nikolay V ^a   Jenkins, Richard O ^b   Radilov, Andrey S ^a  

^a Research Institute of Hygiene Occupational Pathology and Human Ecology   (Russian Federation)

^b DE MONTFORT UNIVERSITY   (United Kingdom)

Author keywords

Aconitase; Compound 1080; Fluoroacetate; Fluorocitrate; Lethal synthesis; Metabolic poison; Monofluorides; TCA; Therapy

Indexed keywords

2 OXOGLUTARIC ACID; ACETAMIDE; ACETIC ACID DERIVATIVE; ACONITATE HYDRATASE; ALCOHOL; ANTIDOTE; ANTINEOPLASTIC AGENT; BARBITURIC ACID DERIVATIVE; CITRIC ACID; COENZYME A; DIAZEPAM; FLUORIDE; FLUORINE DERIVATIVE; FLUOROACETIC ACID; FLUOROCITRIC ACID; FLUOROMALEIC ACID; GLUCONATE CALCIUM; GLUTAMATE DEHYDROGENASE; GLUTAMIC ACID; GLUTATHIONE; GLYCEROL MONOACETATE; INDUSTRIAL CHEMICAL; MALEIC ACID DERIVATIVE; MALIC ACID; NARCOTIC ANALGESIC AGENT; PESTICIDE; PROPRANOLOL; SUCCINIC ACID; THIOL DERIVATIVE; THIOPENTAL; UNCLASSIFIED DRUG; UNINDEXED DRUG;

BOVIDS; CARDIOTOXICITY; CITRIC ACID CYCLE; CLINICAL FEATURE; COMPETITIVE INHIBITION; ENZYME INHIBITION; ENZYME INHIBITOR INTERACTION; HUMAN; INTOXICATION; ISOMER; MEDICAL RESEARCH; METABOLISM; MITOCHONDRION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SYNTHESIS; TOXICOKINETICS;

ACONITATE HYDRATASE; ANIMALS; ANTIDOTES; FLUOROACETATES; HUMANS; NERVOUS SYSTEM DISEASES; POISONING;

ANIMALIA; BOVIDAE; MAMMALIA;

EID: 33645278343     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.1118     Document Type: Review

References (171)

1. Aplin TEH. 1971. Poison plants of Western Australia: the toxic species of Gastrolobium and Oxylobium. West. Aust. Dept Agric. Bull. 3772: 1-66.
2. Andersson U, Leighton B, Young ME, Blomstrand E, Newsholme EA. 1998. Inactivation of aconitase and oxoglutarate dehydrogenase in skeletal muscle in vitro by superoxide anions and/or nitric oxide. Biochem. Biophys. Res. Commun. 249: 512-516.
3. Annison EF, Hill KJ, Lindsay DB, Peters RA. 1960. Fluoroacetate poisoning in sheep. J. Comp. Pathol. 70: 145-155.
4. Aoki C, Milner TA, Sheu KF, Blass JP, Pickel VM. 1987. Regional distribution of astrocytes with intense immunoreactivity for glutamate dehydrogenase in rat brain: implications for neuron-glia interactions in glutamate transmission. J. Neurosci. 7: 2214-2231.
5. Arena IM. 1970. Poisoning: Toxicology - Symptoms - Treatments. C.C. Thomas: Springfield, IL.
6. Arellano M, Malet-Martino M, Martino R, Gires P. 1998. The anticancer drug 5-fluorouracil is metabolized by the isolated perfused rat liver and in rats into highly toxic fluoroacetate. Br. J. Cancer 77: 79-86.
7. Atzert SP. 1971. A Review of Monofluoroacetate (Compound 1080): Its Properties, Toxicology and Use in Predator and Rodent Control. Special Scientific Report no 146. US Dept Interior, Fish and Wildlife Services, Bureau of Sport Fisheries and Wildlife: Washington, DC.
8. Aulerich RJ, Ringer RR, Safronoff J. 1987. Primary and secondary toxicity of warfarin, sodium monofluoroacetate, methyl parathion in mink. Arch. Environ. Contam. Toxicol. 16: 357-366.
9. Baunister DW, O'Neil TE. 1981. Control of gluconeogenesis in chick (Gallum domesticus) isolated hepatocytes. Int. J. Biochem. 13: 437-444.
10. Beaulnes AJC, Panisset J, Brodeur E, Beltrami E, Gariepy G. 1964. Arrhythmias in isolated atria and ventricles and in the intact animal antiarrhythmic effects of some biological polypeptides. Circ. Res. Suppl. 15: 210-214.
11. Benjamin AM, Verjee ZH. 1980. Control of aerobic glycolysis in the brain in vitro. Neurochem. Res. 5: 921-934.
12. Bgin E, Egyed M, Shlosberg A. 1972. Biological-biochemical method for the diagnosis of fluoroacetamide poisoning. II. Certain enzymes and electrolytes. Fluoride 5: 136-144.
13. Bobyleva-Guarriero V, Hughes PE, Lardy HA. 1984. Effect of fluoroacetate on hepatic gluconeogenesis. Fluoride 17: 94-104.
14. Boquist L, Boquist S, Ericsson I. 1988. Structural beta-cell changes and transient hyperglycemia in mice treated with compounds inducing inhibited citric acid cycle enzyme activity. Diabetes 37: 89-98.
15. Bosakowski T, Levin AA. 1986 Serum citrate as a peripheral indicator of fluoroacetate and fluorocitrate toxicity in rats and dogs. Toxicol. Appl. Pharmacol. 85: 428-436.
16. Bowman RH. 1964. Inhibition of citrate metabolism by sodium fluoroacetate in the perfused rat heart and the effect on phosphofructokinase activity and glucose utilization. Biochem. J. 93: 13c-15c.
17. Brand MD, Evans SM, Mendes-Morao J, Chappell JB. 1973. Fluorocitrate inhibition of aconitate hydratase and the tricarboxylate carrier of rat liver mitochondria. Biochem. J. 134: 217-224.
18. Braverman Y. 1979. Experiments on direct and secondary poisoning by fluoroacetamide (1081) in wildlife and domestic carnivores. J. Wildl. Dis. 15: 319-325.
19. Brockmann JL, McDowell AV, Leeds WG. 1955. Fatal poisoning with sodium monofluoroacetate. Report of case. J Am Med Assoc 159: 1529-1532.
20. Buck WB, Osweiler GD, Van Gelder GA. 1976. Fluoroacetate and fluoroacetamide. In Clinical and Diag Vet Toxicol, Vonn Gelder GA (ed.) Kendall-Hunt Pub Co: Iowa; 233-237.
21. Buffa P, Guarriero-Bobyleva V, Costa-Tiozzo R. 1973. Metabolic effects of fluoroacetate poisoning in animals. Fluoride 6: 224-247.
22. Buffa P, Guarriero-Bobyleva V, Pasquali-Ronchetti J. 1972. Biochemical effects of fluoroacetate poisoning in rat liver. In Carbone-Fluorine Compounds, Associated Scientific Compounds: Amsterdam; 303-330.
23. Buffa P, Peters RA. 1950. The in vivo formation of citrate induced by fluoroacetate poisoning and its significance. J. Physiol. 110: 488-500.
24. Burande MD, Goyal RK, Verma SC. 1983. Studies on the mechanism of cardiotonic effects of sodium fluoroacetate and dobulamine. Indian J. Exp. Biol. 21: 150-152.
25. Carrell HL, Glusker JP, Villafranca JJ, Mildvan AS, Dummel RJ, Kun E. 1970. Fluorocitrate inhibition of aconitase: relative configuration of inhibitory isomer by x-ray crystallography. Science 170: 1412-1414.
26. Castro LA, Robalinho RL, Cayota A, Meneghini R, Radi R. 1998. Nitric oxide and peroxynitrite-dependent aconitase inactivation and iron-regulatory protein-1 activation in mammalian fibroblasts. Arch. Biochem. Biophys. 359: 215-224.
27. Chenoweth MB. 1949. Monofluoroacetic acid and related compounds. J. Pharmacol. Exp. Ther. 97: 383-424.
28. Chenoweth MB, Gilman A. 1946. Studies on the pharmacology of fluoroacetate. I. Species response to fluoroacetate. J. Pharmacol. Exp. Ther. 87: 90-103.
29. Cheung PY, Danial H, Jong J, Schulz R. 1998. Thiols protect the inhibition of myocardial aconitase by peroxynitrite. Arch. Biochem. Biophys. 350: 104-108.
30. Chi CH, Chen KW, Chan SH, Wu MH, Huang JJ. 1996. Clinical presentation and prognostic factors in sodium monofluoroacetate intoxication. J. Toxicol. Clin. Toxicol. 34: 707-712.
31. Chi CH, Lin TK, Chen KW. 1999. Hemodynamic abnormalities in sodium monofluoroacetate intoxication. Hum. Exp. Toxicol. 18: 351-353.
32. Chung HM. 1984. Acute renal failure caused by acute monofluoroacetate poisoning. Vet. Hum. Toxicol. 26: 29-32.
33. Cifarelli A, Pepe G, Paradisi F, Piccolo D. 1979. The influence of some metabolic inhibitors on phagocytic activity of mouse macrophages in vitro. Res. Exp. Med. (Berl.) 174: 197-204.
34. Clarke DD. 1991. Fluoroacetate and fluorocitrate: mechanism of action. Neurochem. Res. 16: 1055-1058.
35. Clarke DD, Nicklas WJ. 1970. Tricarboxylic acid cycle metabolism in brain. Biochem. J. 120: 345-351.
36. Cole BT, Engel FL, Fredericks J. 1955. Sodium fluoroacetate diabetes: correlations between glycemia, ketonemia and tissue citrate levels. Endocrinology 56: 675-683.
37. Corsi A, Granata AL. 1967. Differential toxicity of fluoroacetate to heart, kidney and brain mitochondria of the living rat. Biochem. Pharmacol. 16: 1083-1089.
38. Cremer-Lacuara MG, Lacuara JL, Fiol de Cuneo M, Ruiz RD. 1980. Substrate supply and function of isolated venous smooth muscle under anoxia and metabolic inhibition. Can. J. Physiol. Pharmacol. 58: 723-730.
39. Denton RM, Halestrap AP. 1979. Regulation of pyruvate metabolism in mammalian tissues. Essays Biochem. 15: 37-77.
40. De Oliveira MM. 1963. Chromatographic isolation of monofluoroacetic acid from Palicourea marcgravii. Experientia 19: 586-587.
41. Dickson AJ, Langslow DR. 1977. Gluconeogenesis in isolated chicken hepatocytes. Biochem. Soc. Trans. 5: 983-986.
42. Dohi T, Murad F. 1981. Effects of pyruvate and other metabolites on cyclic GMP levels in incubations of rat hepatocytes and kidney cortex. Biochim. Biophys. Acta 673: 14-25.
43. Dorman DC. 1990. Toxicology of selected pesticides, drugs, and chemicals. Anticoagulant, cholecalciferol, and bromethalin-based rodenticides. Vet. Clin. North Am. Small Anim. Pract. 20: 339-352.
44. Eanes RZ, Kun E. 1974. Inhibition of liver aconitase isoenzymes by (-)-erythrofluorocitrate. Mol. Pharmacol. 10: 130-139.
45. Eanes RZ, Skilleter DN, Kun E. 1972. Inactivation of the tricarboxylate carrier of liver mitochondria by (-)-erythrofluorocitrate. Biochem. Biophys. Res. Commun. 46: 1618-1622.
46. Eason CT, Gooneratne R, Fitzgerald H, Wright G, Frampton C. 1994. Persistence of sodium monofluoroacetate in livestock animals and risk to humans. Hum. Exp. Toxicol. 13: 119-122.
47. Eason CT, Turck P. 2002. A 90-day toxicological evaluation of Compound 1080 (sodium monofluoroacetate) in Sprague-Dawley rats. Toxicol. Sci. 69: 439-447.
48. Egekeze JO, Oehme FW. 1979a. Inorganic and organic fluoride concentrations in tissues after the oral administration of sodium monofluoroacetate (Compound 1080) to rats. Toxicology 15: 43-53.
49. Egekeze JO, Oehme FW. 1979b. Sodium monofluoroacetate (SMFA, compound 1080): a literature review. Vet. Hum. Toxicol. 21: 411-416.
50. Egyed MN. 1971. Experimental acute fluoroacetamide poisoning in sheep. III. Therapy. Refu. Vet. 28: 70-73.
51. Egyed MN. 1973. Clinical, pathological, diagnostic and therapeutic aspects of fluoroacetate research in animals. Fluoride 6: 215-223.
52. Egyed M, Brisk Y. 1965. Experimental fluoroacetamide poisoning in mice, rats and sheep. Refu. Vet. 22: 274-278.
53. Egyed MN, Schultz RA. 1986. The efficacy of acetamide for the treatment of experimental Dichapetalum cymosum (gifblaar) poisoning in sheep. Onderstepoort J. Vet. Res. 53: 231-234.
54. Egyed MN, Shlosberg A. 1973. Diagnosis of field cases of sodium fluoroacetate and fluoroacetamide poisoning in animals. Refu. Vet. 30: 112-115.
55. Egyed MN, Shlosberg A. 1977. The efficiency of acetamide in the prevention and treatment of fluoroacetamide poisoning in chickens. Fluoride 10: 34-37.
56. Egyed M, Shupe J. 1971. Experimental acute fluoroacetamide poisoning in sheep and dogs. I. Symptomatology and pathology. Fluoride 4: 129-136.
57. Elliott WB, Phillips AH. 1954. Effect of fluoroacetate on glucose metabolism in vivo. Arch. Biochem. Biophys. 49: 389-395.
58. Engel FL, Hewson K, Cole BT. 1954. Carbohydrate and ketone body metabolism in the sodium fluoroacetate poisoned rats 'SPA' diabetes. Am. J. Physiol. 179: 325-332.
59. Erlichman JS, Li A, Nattie EE. 1998. Ventilatory effects of glial dysfunction in a rat brain stem chemoreceptor region. J. Appl. Physiol. 85: 1599-1604.
60. Fairhurst AS, Smith RE, Gal BM. 1958. The effects of fluoro-compounds on oxidative phosphorylation. Biochem. Pharmacol. 1: 273-279.
61. Fanshier DW, Gottwald LK, Kun E. 1964. Studies on specific enzyme inhibitors. VI. Characterization and mechanism of action of the enzyme-inhibitory isomer of monofluorocitrate. J. Biol. Chem. 239: 425-434.
62. Feldwick MG, Noakes PS, Prause U, Mead RJ, Kostyniak PJ. 1998. The biochemical toxicology of 1,3-difluoro-2-propanol, the major ingredient of the pesticide gliftor: the potential of 4-ethylpyrazole as an antidote. J. Biochem. Mol. Toxicol. 12: 41-52.
63. Fonnum F, Johnsen A, Hassel B. 1997. Use of fluorocitrate and fluoroacetate in the study of brain metabolism. Glia 21: 106-113.
64. Gajdusek DC, Lutheer G. 1950. Fluoroacetate poisoning. A review and report of a case. Am. J. Dis. Child. 79: 310-320.
65. Gammie J. 1980. Sodium fluoroacetate poisoning in a cat. Can. Vet. J. 21: 64.
66. Gardner PR, Nguyen DD, White CW. 1994. Aconitase is a sensitive and critical target of oxygen poisoning in cultured mammalian cells and in rat lungs. Proc. Natl Acad. Sci. USA 91: 12248-12252.
67. Gawron O, Mahajan KP. 1966. α-Methyl-cis-aconitic acid, cis-aconitase substrate. II. Substrate properties and aconitase mechanism. Biochemistry 5: 2343-2350.
68. Giller S. 1956. The influence of acetamide on citrate accumulation after fluoroacetate poisoning. Biochem. J. 63: 182-187.
69. Giller S, Blank I, Bergmann ED. 1953. Studies of organic fluoride compounds. 1. The influence of acetamide on fluoroacetate poisoning. Nederlandse Academic van Wetenschappen. S 54: 423-426.
70. Godoy HM, Cignoli EV, Castro JA. 1968. Effect of fluoroacetate poisoning in the glycogen content of rat heart and skeletal muscle. Life Sci. 7: 847-854.
71. Gooneratne SR, Eason CT, Dickson CJ, Fitzgerald H, Wright G. 1995. Persistence of sodium monofluoroacetate in rabbits and risk to non-target species. Hum. Exp. Toxicol. 14: 212-216.
72. Gosselin RE, Hodge HC, Smith RP, Cleason MN. 1976. Clinical Toxicology of Commercial Products. Williams and Wilkins: Baltimore.
73. Hall RJ. 1972. The distribution of organic fluorine in some toxic tropical plants. New Phytol. 71: 855-871.
74. Harrison JWE, Ambrus JL, Ambrus CM, Rees EW, Peters RH Jr, Reese LC. 1952. Acute poisoning with sodium fluoroacetate (compound 1080). JAMA 149: 1520-1522.
75. Hassel, B, Sonnewald U, Unsgard G, Fonnum F. 1994. NMR spectroscopy of cultured astrocytes: effects of glutamine and the gliotoxin fluorocitrate. J. Neurochem. 62: 2187-2194.
76. Hayes WJ. 1963. Clinical Handbook on Economic Poisons. Public Health Service: Atlanta.
77. Hayes WJ, Laws ER. 1991. Handbook of Pesticide Toxicology, Vol 3: Classes of Pesticides. Academic Press: New York.
78. Hertz L, Gibbs ME, O'Dowd BS, Sedman GL, Robinson SR, Sykova E, Hajek I, Hertz E, Peng L, Huang R, Ng KT. 1996. Astrocyte-neuron interaction during one-trial aversive learning in the neonate chick. Neurosci. Biobehav. Rev. 20: 537-551.
79. Holleran J, Babbie M, Erlichman JS. 2001. Ventilatory effects of impaired glial function in a brain stem chemoreceptor region in the conscious rat. J. Appl. Physiol. 90: 1539-1547.
80. Hornfeldt CS, Larson AA. 1990. Seizures induced by fluoroacetic acid and fluorocitric acid may involve chelation of divalent cations in the spinal cord. Eur. J. Pharmacol. 179: 307-313.
81. Huang TY, Pang XQ, Ch'ang HL. 1980. Prophylactic effect of reserpine in cardiac failure caused by monofluoroacetic acid derivatives. Acta Pharm. Toxicol. 47: 78-80.
82. Hulsmann S, Straub H, Richter DW, Speckmann EJ. 2003. Blockade of astrocyte metabolism causes delayed excitation as revealed by voltage-sensitive dyes in mouse brainstem slices. Exp. Brain Res. 150: 117-121.
83. Hutchens JO, Wagner H, Podolsky B, McMagon T. 1949. The effect of ethanol and various metabolites on fluoroacetate poisoning. J. Pharmacol. Exp. Ther. 95: 62-69.
84. Iles JF, Jack JJ. 1980. Ammonia: assessment of its action on post-synaptic inhibition as a cause of convulsions. Brain 103: 555-578.
85. Karam JH, Grodsky GM. 1962. Insulin content of pancreas after sodium fluoroacetate-induced hyperglycemia. Proc. Soc. Exp. Biol. Med. 109: 451-453.
86. Keller DA, Roe DC, Lieder PH. 1996. Fluoroacetate-mediated toxicity of fluorinated ethanes. Fundam. Appl. Toxicol. 30: 213-219.
87. Kent TA, Emptage MH, Merkle H, Kennedy MC, Beinert H, Munck E. 1985. Mossbauer studies of aconitase. Substrate and inhibitor binding, reaction intermediates, and hyperfine interactions of reduced 3Fe and 4Fe clusters. J. Biol. Chem. 260: 6871-6881.
88. Kirsten E, Sharma ML, Kun E. 1978. Molecular toxicity of (-)-erythrofluorocitrate: Selective inhibition of citrate transport in mitochondria and the binding of fluorocitrate to mitochondrial proteins. Mol. Pharmacol. 14: 172-184.
89. 31P NMR study. Mol. Cell. Biochem. 244: 77-81.
90. Koenig H, Patel A. 1970. Biochemical basis for fluorouracil neurotoxicity: the role of Krebs cycle inhibition by fluoroacetate. Arch. Neurol. 23: 155-160.
91. Konstantinova SG, Russanov EM. 1996. Aconitase activity in rat liver. Comp. Biochem. Physiol. B: Biochem. Mol. Biol. 113: 125-130.
92. Kun E. 1969. Mechanism of action of fluoro analogs of citric acid cycle compounds: an essay on biochemical tissue specificity. In Citric Acid Cycle, Control and Compartmentarion, Lowenstein JM (ed.). Marcel Dekker, Inc: New York; 297-339.
93. Lauble H, Kennedy MC, Beinert H, Stout CD. 1992. Crystal structures of aconitase with isocitrate and nitroisocitrate bound. Biochemistry 38: 2735-2748.
94. Lauble H, Kennedy MC, Beinert H, Stout CD. 1994. Crystal structures of aconitase with trans-aconitate and nitrocitrate bound. J. Mol. Biol. 237: 437-451.
95. Lauble H, Kennedy M, Emptage M, Stout C. 1996. The reaction of fluorocitrate with aconitase and the crystal structure of the enzyme-inhibitor complex. Proc. Natl Acad. Sci. USA 93: 13699-13703.
96. Lian XY, Stringer JL. 2004. Energy failure in astrocytes increases the vulnerability of neurons to spreading depression. Eur. J. Neurosci. 19: 2446-2454.
97. Liang C. 1977. Metabolic control of circulation. Effects of iodoacetate and fluoroacetate. J. Clin. Invest. 60: 61-69.
98. Marais JSC. 1944. Monofluoroacetic acid, the toxic principle of 'Gifblaar', Dichapetalum cymosum (Hook). J. Vet. Sci. Anim. Ind. 20: 67-73.
99. Max SR, Purvis JL. 1965. Energy-linked incorporation of citrate into rat liver mitochondria. Biochem. Biophys. Res. Commun. 21: 587-594.
100. Maytnert EW, Kaji HK. 1962. On the relationship of brain γ-aminobutyric acid to convulsions. J. Pharmacol. Exp. Ther. 137: 114-121.
101. McCosker T. 1989. Ruminal detoxification of fluoroacetate. Agric. Sci. New Ser. 2: 46-47.
102. McEwan T. 1964. Isolation and identification of the toxic principle of Gastrolobium grandiflorum. Qld J. Agric. Sci. 21: 1-14.
103. McTaggart DR. 1970. Poisoning due to sodium fluoroacetate ('1080'). Med. J. Aust. 2: 641-642.
104. Mead RJ, Moulden DL, Twigg LB. 1985. Significance of sulfhydryl compounds in the manifeatation of fluoroacetate toxicity to the rat (Rattus fuscipes), brush-tailed possum (Frichosurus vulpecula), woylic (Bettongonia penicillata) and Western grey kangaroo (Macropus fulignosus ocydromus). Aust. J. Biol. Sci. 38: 39-149.
105. Mead RJ, Oliver AJ, King DR. 1979. Metabolism and defluorination of fluoroacetate in the brush-tailed possum (Trichosurus vulpecula). Aust. J. Biol. Sci. 32: 15-26.
106. Miller AL, Kiney CA, Cordry DH, Staton DM. 1982. Interaction between glucose and ketone body use by developing brain. Dev. Brain Res. 256: 443-450.
107. Minnaar PP, McCrindle RI, Naude TW, Botha CJ. 2000. Investigation of biological samples for monofluoroacetate and Dichapetalum cymosum poisoning in southern Africa. Onderstepoort J. Vet. Res. 67: 27-30.
108. Montoya CMA, Lopez MG. 1983. Treatment of sodium fluoroacetate intoxication. Rev. Med. Inst. Mex. Seguro Soc. 21: 125-128.
109. Muir D, Berl S, Clarke DD. 1986. Acetate and fluoroacetate as possible markers for glial metabolism in vivo. Brain Res. 380: 336-340.
110. Norris WR. 2001. Sodium fluoroacetate. IPCSINTOX Databank, Poison Information Monograph 494.
111. Nwude N, Parsons LE, Adaudi AO. 1977. Acute toxicity of the leaves and extracts of Dichapetalum harten (Engl.) in mice, rabbits and goats. Toxicology 7: 23-29.
112. Oerlichs PB, McEwan T. 1961. Isolation of the toxic principle of Acacia georginae. Nature (Lond.) 190: 808-809.
113. Omara F, Sisodia CS. 1990. Evaluation of potential antidotes for sodium fluoroacetate in mice. Vet. Hum. Toxicol. 32: 427-431.
114. Orkand RK, Opava S. 1994. Glial function in homeostasis of the neuronal microenvironment. News Physiol. Sci. 9: 265-267.
115. Patel A, Koenig H. 1968. The neurochemical effects of fluorocitrate. Neurology 18: 296.
116. Pattison FLM. 1959. Toxic Aliphatic Fluorine Compounds. Elsevier: London.
117. Paulsen RE, Contestabile A, Vildani L, Fonnum F. 1987. An in vivo model for studying function of brain tissue temporarily devoid of glial cell metabolism: the use of fluorocitrate. J. Neurochem. 48: 1377-1385.
118. Perez GA, Frindt G. 1977. The effect of fluorocitrate on urinary calcium and citrate excretion. Experientia 33: 741-742.
119. Peters RA. 1952. Lethal synthesis. Prof. R. Soc. (Lond.) 139: 143-175.
120. Peters RA. 1972. Some metabolic aspects of fluoroacetate especially related to fluorocitrate. In Carbon Fluorine Compounds. A Ciba Foundation Symposium. Associated Scientific Pub: Amsterdam; 55-70.
121. Peters RA, Shorthouse M, Ward PF, McDowell EM. 1972. Observations upon the metabolism of fluorocitrate in rats. Proc. R. Soc. (Lond.) B Biol. Sci. 182: 1-8.
122. Prasanna CV, Ramakrishnan S. 1984. Effect of acetaldehyde on carbohydrate metabolism in rat brain. Indian J. Biochem. Biophys. 21: 121-123.
123. Pridmore SA. 1978. Fluoroacetate poisoning: nine years later. Med. J. Aust. 2: 269-270.
124. 2FOOK), [Dichapetalum cymosum (Hook) Engl.] toxin on animals. J. Vet. Sci. Animal Ind. 22: 77-90.
125. Rammel CG, Hoogenboom IL, Julian AF. 1985. Treatment of 1080 poisoning in dogs with glycerol monoacetate. N. Z. Vet. J. 33: 149-150.
126. Ransom B. 1995. Gap junctions. In Neuroglia, Kettenmann H, Ransom BR (eds). Oxford University Press: New York: 299-319.
127. Reichelt H. 1979. [What is fluoroacetate diabetes?] [Article in German]. Z. Gesamte Inn. Med. 34: 401-404.
128. Reifenrath WG, Roche EB, Al-Turk WA, Johnson HL. 1980. Synthesis and biological activity of fluoroalkylamine derivatives of narcotic analgesics. J. Med. Chem. 23: 985-990.
129. Reigart JR, Brueggman JL, Pharm D, Keil E. 1975. Sodium fluoroacetate poisoning. Am. J. Dis. Child. 129: 1124-1126.
130. Robinson RF, Griffith JR, Wolowich WR, Nahata MC. 2002. Intoxication with sodium monofluoroacetate (compound 1080). Vet. Hum. Toxicol. 44: 93-95.
131. Rompp A, Klemm O, Fricke W, Frank H. 2001. Haloacetates in fog and rain. Environ. Sci. Technol. 35: 1294-1298.
132. Roy (Shapira) A, Raikhlin EB, Taitelman U, Hazani A. 1982. Acute poisoning due to fluoroacetate and fluoroacetamide. Harefuah 102: 523-524.
133. Roy (Shapira) A, Taitelman U, Bursztein S. 1980. Evaluation of the role of ionized calcium in sodium fluoroacetate ('1080') poisoning. Toxicol. Appl. Pharmacol. 56: 216-220.
134. Saito T. 1990. Glucose-supported oxidative metabolism and evoked potentials are sensitive to fluoroacetate, an inhibitor of glial tricarboxylic acid cycle in the olfactory cortex slice. Brain Res. 535: 205-213.
135. 2+ signaling in single mouse beta-cells. Endocrinology 141: 4065-4071.
136. Schultz RA, Coetzer JA, Kellerman TS, Naude TW. 1982. Observations on the clinical, cardiac and histopathological effects of fluoroacetate in sheep. Onderstepoort J. Vet. Res. 49: 237-245.
137. Schurr A, Payne RS, Miller JJ, Rigor BM. 1997. Glia are the main source of lactate utilized by neurons for recovery of function posthypoxia. Brain Res. 774: 221-224.
138. Sherley M. 2004. The traditional categories of fluoroacetate poisoning signs and symptoms belie substantial underlying similarities. Toxicol. Lett. 151: 399-406.
139. Soiefer AI, Kostyniak PJ. 1983. The enzymatic defluorination of fluoroacetate in mouse liver cytosol: the separation of defluorination activity from several glutathione S-transferases of mouse liver. Arch. Biochem. Biophys. 225: 928-935.
140. Soiefer AI, Kostyniak PJ. 1984. Purification of a fluoroacetate specific defluorinase from mouse liver cytosol. J. Biol. Chem. 259: 10787-10792.
141. Spoerke DG, Smolinske SC, Wruk KM, Rumack BH. 1986. Infrequently used antidotes: indications and availability. Vet. Hum. Toxicol. 28: 69-75.
142. Stewart GG, Abbs ET, Roberts DJ. 1970. Biochemical effects of fluoroacetate administration in rat brain, heart and blood. Biochem. Pharmacol. 19: 1861-1866.
143. Swanson RA, Graham SH. 1994. Fluorocitrate and fluoroacetate effects on astrocyte metabolism in vitro. Brain Res. 664: 94-100.
144. Sytinskii IA, Kopelevich VM, Nikitina ZS, Polevoy LG. 1986. [Alcohol intoxication and brain GABA under Pantogam and Fenibut administration] [Article in Russian] Pharmacol. Toxicol. (Moscow) 2: 79-82.
145. Szerb JC, Issekutz B. 1987. Increase in the stimulation-induced overflow of glutamate by fluoroacetate, a selective inhibitor of the glial tricarboxylic cycle. Brain Res. 410: 116-120.
146. Szerb JC, O'Regan PA. 1988. Increase in the stimulation-induced overflow of excitatory amino acids from hippocampal slices: interaction between low glucose concentration and fluoroacetate. Neurosci. Lett. 86: 207-212.
147. Szerb JC, Redondo IM. 1993. Astrocytes and the entry of circulating ammonia into the brain: effect of fluoroacetate. Metab. Brain Dis. 8: 217-234.
148. Taitelman U, Roy (Shapira) A, Hoffer E. 1983a. Fluoroacetamide poisoning in man: the role of ionized calcium. Arch. Toxicol. Suppl. 6: 228-231.
149. Taitelman U, Roy (Shapira) A, Raikhlin-Eisenkraft B, Hoffer E. 1983b. The effect of monoacetin and calcium chloride on acid-base balance and survival in experimental sodium fluoroacetate poisoning. Arch. Toxicol. Suppl. 6: 222-227.
150. Taylor WM, D'Costa M, Angel A, Halperin ML. 1977. Insulin-like effects of fluoroacetate on lipolysis and lipogenesis in adipose tissue. Can. J. Biochem. 55: 982-987.
151. 15C NMR. Chem. Res. Toxicol. 2: 429-435.
152. Temple WA, Edwards JR. 1985. Toxic ducks - 1080 residues in game birds: an exercise in applied toxicology. Vet. Hum. Toxicol. 27: 20-22.
153. Tisdale MJ, Brennan RA. 1985. Role of fluoroacetate in the toxicity of 2-fluroethylnitrosoureas. Biochem. Pharmacol. 34: 3323-3327.
154. Tourtelotte WW, Coon JM. 1949. Synergistic effect of sodium acetate and ethanol in antagonizing sodium fluoroacetate poisoning in mice. Fed. Proc. 8: 339-350.
155. Trabes J, Rason N, Avrahami E. 1983. Computed tomography demonstration of brain damage due to acute sodium monofluoroacetate poisoning. J. Toxicol. Clin. Toxicol. 20: 85-92.
156. Turner AJ, Whittle SR. 1983 Biochemical dissection of the gamma-aminobutyrate synapse. Biochem. J. 209: 29-41.
157. Twigg LE, Mead RJ, King DR. 1986. Metabolism of fluoroacetate in the skink (Tiliqua rugosa) and the rat (Rattus norvegicus). Aust. J. Biol. Sci. 39: 1-15.
158. Vernadakis A. 1996. Glia-neuron intercommunications and synaptic plasticity. Prog. Neurobiol. 49: 185-214.
159. Vickery B, Vickery ML, Ashu JT. 1973. Analysis of plants for fluoroacetic acid. Phytochemistry 12: 145-147.
160. Villafranca JJ, Platus E. 1973. Fluorocitrate inhibition of aconitase: reversibility of the inactivation. Biochem. Biophys. Res. Commun. 55: 1197-1207.
161. Wang SL, Rice SA, Serra MT, Gross B. 1986. Purification and identification of rat hepatic cytosolic enzymes responsible for defluorination of methoxyflurane and fluoroacetate. Drug Metab. Dispos. 14: 392-398.
162. Waniewski RA, Martin DL. 1998. Preferential utilization of acetate by astrocytes is attributable to transport. J. Neurosci. 18: 5225-5233.
163. 2+ of NMDA receptor mediated channel current neurotransmitter release. Procr. Natl Acad. Sci. USA 92: 3367-3370.
164. Westergaard N, Sonnewald U, Unsgard G, Peng L, Hertz L, Schousboe A. 1994. Uptake, release and metabolism of citrate in neurons and astrocytes in primary cultures. J. Neurochem. 62: 1727-1733.
165. Wiedemann P, Szinicz L, Weger N. 1983. Biochemical aspects of fluoroacetate poisoning in isolated rat kidney tubules: reversibility of inhibition of gluconeogenesis by α-ketoglutarate. Arch. Toxicol. Suppl. 6: 232-237.
166. Williamson JR. 1967. Glycolytic control mechanisms. III. Effects of iodoacetamide and fluoroacetate on glucose metabolism in the perfused rat heart. J. Biol. Chem. 242: 4476-4485.
167. Yamashita K, Yada H, Ariyoshi T. 2004. Neurotoxic effects of alpha-ftuoro-beta-alanine (FBAL) and fluoroacetic acid (FA) on dogs. J. Toxicol. Sci. 29: 155-166.
168. Yeh KH, Cheng AL. 1994. Acute confusion induced by a high-dose infusion of 5-fluorouracil and folinic acid. J. Formos. Med. Assoc. 93: 721-723.
169. Yu HL, Giammarco R, Goldstein MB, Stinepaugh DJ, Halperin ML. 1976. Stimulation of ammonia production and excretion in the rabbit by inorganic phosphate: study of control mechanisms. J. Clin. Invest. 58: 557-564.
170. Zhou J, Kauffman FC, Ballow CH, Thurman RG. 1984. Inhibition of mixed-function oxidation in perfused rat liver by fluoroacetate treatment. Biochem. Pharmacol. 33: 319-323.
171. Zieve L, Lyftogt C, Draves K. 1983. Toxicity of a fatty acid and ammonia: interactions with hypoglycemia and Krebs cycle inhibition. J. Lab. Clin. Med. 101: 930-939.